Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Age-specific Epstein-Barr virus seroprevalence in Costa Rica.

Created on 11 Nov 2026

Authors

Sabrina Acosta-Egea, Elexandra Barboza Arguedas, Eva Villalobos Chacón, Romain Fantin, Carolina Porras, Viviana Loria, Juan Carlos Venegas, Connie M Weston, Sarah S Jackson, Arturo Abdelnour, Amada Aparicio, Alejandro Calderón, Daniela Mora, Rebeca Ocampo, Roy Wong-McClure, Melvin Morera, Roberto Castro, Henry H Balfour, Rolando Herrero, Allan Hildesheim

Published in

PloS one. Volume 21. Issue 11. Pages e0362125. Epub Nov 10, 2026.

Abstract

Epstein-Barr Virus (EBV) is a common herpesvirus linked to cancers and autoimmune diseases. The age, socioeconomic status and geographic distribution of EBV infection are varied. This study evaluated age-specific EBV antibody prevalence in Costa Rica among 2,990 participants in a population-based cohort that enrolled in 2020/1. Seropositivity prevalence was age-dependent, with rates over 80% in adolescents, and higher than 90% in adults 20 + . Geometric mean levels (GML) of antibodies among seropositives also rose with age, peaking in older adults. The age at seroconversion was slightly younger in boys than in girls and for individuals in rural/mixed areas, but seropositivity of 90% or more was found in both sexes and all regions of residence in adults. Among seropositives, there was a tendency for women to have higher GML compared with men. Our findings provide information regarding the age-specific distribution of EBV in Costa Rica, which is useful for planning future health measures to reduce the burden of EBV-associated conditions.

PMID:
43008058
Bibliographic data and abstract were imported from PubMed on 11 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 11
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement